Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Pelles Sharon
23 années d'expérience
La clinique est certifiée :
| Israël | Turquie | Espagne | |
| Thérapie par faisceau de protons | de $48,000 | de $70,000 | de $25,790 |
| NanoCouteau | de $18,500 | de $9,500 | de $12,000 |
| CyberCouteau | de $17,500 | de $4,750 | de $30,000 |
| Couteau gamma | de $13,800 | de $6,300 | de $18,000 |
| Chirurgie du cancer du pancréas | de $38,000 | de $9,000 | de $35,000 |
Le Dr Sharon Peles est spécialisée dans les tumeurs gastro-intestinales, formée au prestigieux Royal Marsden Cancer Center de Londres.
Le professeur Merimsky est spécialisé dans le cancer du pancréas, avec des décennies d'expérience en oncologie au Sourasky Medical Center.
Le professeur Nadir Arber se consacre exclusivement aux cancers gastro-intestinaux depuis plus de 30 ans. Il dirige le centre de prévention du cancer au célèbre centre médical Sourasky en Israël.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.